威高股份2023年报

CONTE目NT录S CORPORATEINFORMATION 公司资料 2 CHAIRMAN’SSTATEMENT 主席报告书 4 FINANCIALHIGHLIGHTS 财务摘要 9 MANAGEMENTDISCUSSIONANDANALYSIS 管理层讨论与分析 13 DIRECTORS,SUPERVISORSANDSENIORMANAGEMENT 董事、监事及高级管理人员 29 REPORTOFTHESUPERVISORYCOMMITTEE 监事会报告书 37 REPORTOFTHEDIRECTORS 董事会报告 39 CORPORATEGOVERNANCEREPORT 企业管治报告 67 INDEPENDENTAUDITOR’SREPORT 独立核数师报告书 87 CONSOLIDATEDSTATEMENTOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME 综合损益及其他全面收入报表 93 CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION 综合财务状况表 95 CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY 综合权益变动报表 97 CONSOLIDATEDSTATEMENTOFCASHFLOWS 综合现金流量报表 99 NOTESTOTHECONSOLIDATEDFINANCIALSTATEMENTS 综合财务报表附注 102 C公O司RP资O料RATEINFORMATION DirectorsandSupervisors ExecutiveDirectors Mr.LONGJing(Chairman) Mr.CONGRinan(ChiefExecutiveOfficer) Mr.LUJunqiang Non-executiveDirectors Mr.TANGZhengpeng(ViceChairman) Mr.CHENLin IndependentNon-executiveDirectors Mr.LIGuohui Mrs.MENGHongMr.LIQiang Supervisors Mrs.GUMeijunMr.SONGDapeng Mr.ZHANGZhuangqiu CorporateInformation RegisteredofficeandprincipalplaceofbusinessinthePRC 1WeigaoRoad TorchHi-techScienceParkWeihai ShandongProvincePRC PrincipalplaceofbusinessinHongKong 29/F. TwoChinachemCentral 26DesVoeuxRoadCentralHongKong Companysecretary Mrs.WONGMiuLing,Phillis,FCGandHKFCG Complianceofficer Mr.LONGJing 董事及监事 执行董事 卢均强先生 龙丛经日先楠先生（生主（行席）政总裁） 非执行董事 汤陈正林鹏先先生生（副主席） 独立非执行董事 孟红女士 李国辉先生李强先生监事 宋大鹏先生 谷美君女士张壮秋先生公司资料 中国注册办事处及主要营业地点 中山国东省 威高路1号 威火海炬市高技术产业开发区 香港主要营业地点 德辅道中26号 香港 华懋中心II期29楼 公司秘书 黄妙玲女士FCG及HKFCG 监察主任 龙经先生 AuditCommittee Mr.LIGuohui(Chairman) Mrs.MENGHongMr.LIQiang Mr.TANGZhengpeng RemunerationCommittee Mr.LIGuohui(Chairman) Mrs.MENGHongMr.LIQiang Mr.TANGZhengpeng NominationCommittee Mr.LIGuohui(Chairman) Mrs.MENGHongMr.LIQiang Mr.TANGZhengpeng CorporateGovernanceCommittee Mr.LONGJing(Chairman) Mr.LIGuohui Mrs.MENGHongMr.LIQiang Authorisedrepresentatives Mr.LONGJing Mrs.WONGMiuLing,Phillis Auditors DeloitteToucheTohmatsu CertifiedPublicAccountants RegisteredPublicInterestEntityAuditors Hshareregistrarandtransferoffice TricorStandardLimited 17thFloor,FatEastFinanceCentre16HarcourtRoad HongKong Principalbankers AgricultureBankofChina,WeihaiBranchBankofChina,WeihaiBranch Website www.weigaogroup.com Stockcode 1066 CORPORATEINFOR公M司AT资IO料N 审核委员会 李孟国红辉女先士生（主席）李汤强正先鹏生先生 薪酬委员会 李孟国红辉女先士生（主席）李汤强正先鹏生先生 提名委员会 李孟国红辉女先士生（主席）李汤强正先鹏生先生 企业管治委员会 龙李经国先辉先生（生主席）孟李红强女先士生 授权代表 龙黄经妙先玲生女士 核数师 执业会计师 德勤•关黄陈方会计师行 注册公众利益实体核数师 香港H股股份过户登记处 卓香佳港标准有限公司夏远悫东道金1融6中号心17楼 主要往来银行 中国农银业行－银威行海－威市海分市行分行 本公司网址 www.weigaogroup.com 股份代号 1066 DearShareholders,PartnersandColleagues, 2024marksthe20thanniversaryofthelistingofShandongWeigaoGroupMedicalPolymerCompanyLimited(“Weigao”orthe“Company”)inHongKong.Throughtwodecadesofdevelopment,Weigaohasgrowntobecomeanindustry-leadingenterpriseinthemedicaldevicesandconsumablessectorinChina,anditsmarketshareandpositionintheindustryhaveimprovedtremendouslyinvariousbusinesslinesincludingclinicalcareconsumables,orthopaedicconsumables,pharmaceuticalpackagingandbloodtechnology. Compoundedbyvariousfactors,theresultsgrowthoftheCompanywasunderpressurelastyear.However,theCompanystillsecuredhard-wonachievements.Althoughfluctuationswereseeninoperatingresults,however,wearepleasedtoseestrongsalesgrowthacrossourmajorproductsandalsocontinuousrapidgrowthinourmarketshare.Despitesuchshort-termheadwinds,themanagementfocusedonhigh-qualitydevelopmentandafarsightedandlong-termlayout,whichhasunderpinnedWeigao’ssustainablegrowthinthefuture. Asaleadingdomesticplatform-basedmedicaldevicescompany,Weigaoenjoyssignificantcompetitivenessinthefollowingaspects: 1)Outstandingcorporatecultureand distinguishedmarketreputationandbrandinfluence. TheCompanyalwayspracticesthecorporatecultureofconscience,sincerityandloyaltytomeetclinicaldemand.Withrigidend-usermarketdemand,theimplementationofvolume-basedprocurementsandefficiencyimprovementintheindustrialchainformedicaldevicesandconsumableshaveputtheCompanyinahighlyfavourablepositiontorapidlyexpanditsmarketshareandenhanceitspositionandinfluenceintheindustry. 2)Advantageofanopen,inclusiveandsharedplatform. TheCompanypromotesthesynergy,cooperationandsharingofresourcesamongvarioussegmentstofullyrevitalizetheflexibilityandvibrancyofallsegments.Throughstrategicrecalibration,theCompanyactivelycultivatesanddeploysnewbusinesssegmentstofosterthemintonewgrowthpoints. 尊同事敬：的各位股东、各位合作伙伴、各位 2股0份24有年限是公山司东（“威威高高集”团或医“公用司高”分）在子香制港品上威高市2已0经周成年长纪为念。中经国过医这疗2器0年械、的耗发材展领，域骨的科行耗业材、龙药头品企包业装，、在血临液床技护术理等耗各材领、域提，升市。场份额和行业地位都得到了巨大 去长年面，临在压各力种，因但素取迭得加的下成，绩公也司实业属绩不增易然。看虽到然，各经主营要业产绩品有的所销波量动，增但长我强们劲欣，公有司短的期市的场挫份折，额但在管持理续层快着速眼增于长高。质虽量然发来持展，续高成瞻长远的瞩基、础布。局长远，这是威高未 威司，高在是以国下内几领个先方的面医有显疗着器的械竞平争台力型：公 1)和优品秀牌的影企响业文力。化、卓越的市场口碑 公企司业始文终化，践满行足良临心床、诚需心求、。忠产心品的市施，场医刚疗需器强械，、随耗着材带的量产采业购链的效实率优场份化，额极，提大升有行利业于地公位司和快影速响提力升。市 2)开放、包容和共享的平台优势。 为新的增长点。 公源司共推享，动充各分板激块发的各协板同块、合的作灵和活资性和培育活和力。布公局司新通的过业战务略板梳块，理以，积期极成 3)Solidmanufacturingfoundations. TheCompanyenjoysdistinctadvantagesinautomation,materialsscience,costcontrol,capacitylayoutandqualitycontrolandfullymeetsthedemandforvolume-basedprocurementsonpricea